Novartis To Continue Heavy Investment In China Market, CEO Says
This article was originally published in PharmAsia News
Executive Summary
Novartis CEO Joseph Jimenez says his firm expects to exploit China's changing and expanding market to increase the nation's share of the company's emerging-market sales, to 30% by 2015.